All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • icovamenibPhase 22 trials

    Biomea Fusion Inc. · Type 2 Diabetes

  • ICP-723Phase 22 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Advanced Solid Tumors Harboring NTRK Fusion, Primary Central Nervous System Tumors Harboring NTRK Fusion, Solid Tumors

  • IDP-121Phase 22 trials

    IDP Discovery Pharma S.L. · Small Cell Lung Cancer ( SCLC ), Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

  • IfetrobanPhase 22 trials

    Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited

  • IMGN632Phase 22 trials

    AbbVie · Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm, Acute Myeloid Leukemia

  • IMM01-STEMPhase 22 trials

    Immunis, Inc. · Muscle Performance, Sarcopenic Obesity, Muscle Atrophy

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • INO-5401Phase 22 trials

    Inovio Pharmaceuticals · Glioblastoma, Urothelial Carcinoma

  • T-MAXIMUM Pharmaceutical Inc · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Brain Metastases From Solid Tumors

  • Laboratoires Thea · Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind

  • IPG7236Phase 22 trials

    Nanjing Immunophage Biotech Co., Ltd · Advanced Solid Tumor, Safety Issues, Tolerability

  • IsuzinaxibAPX-115Phase 22 trials

    Aptabio Therapeutics, Inc. · Diabetic Kidney Disease (DKD), Contrast Induced Acute Kidney Injury

  • itacitinibINCB039110Phase 22 trials

    Incyte · B-Cell Malignancies, Lung Cancer

  • JAB-8263Phase 22 trials

    Jacobio Pharmaceuticals Co., Ltd. · Rheumatoid Arthritis (RA), NSCLC, SCLC

  • JMT108Phase 22 trials

    Shanghai JMT-Bio Inc. · Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors, Advanced Malignant Tumors

  • JNJ-95597528Phase 22 trials

    Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma

  • JR-446Phase 22 trials

    JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis III-B, Mucopolysaccharidosis IIIB

  • JS207Phase 22 trials

    Mabwell (Shanghai) Bioscience Co., Ltd. · Solid Tumor, Advanced Solid Tumor

  • JYP0061Experimental Drug GroupPhase 22 trials

    Guangzhou JOYO Pharma Co., Ltd · Moderate-to-severe Atopic Dermatitis, Neuromyelitis Optica Spectrum Disorders

  • KB707Phase 22 trials

    Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV

  • KCBT-1083BEBT-109Phase 22 trials

    BeBetter Med Inc · Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation

  • KDS2010Phase 22 trials

    NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients

  • KH-001Phase 22 trials

    Kadence Bio · Premature Ejaculation, Dentin Hypersensitivity

  • KHK4951Phase 22 trials

    Kyowa Kirin Co., Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD)

  • KL1333NapazimonePhase 22 trials

    Pharming Technologies B.V. · Primary Mitochondrial Disease, Mitochondrial Diseases

  • KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials

    InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer

  • KN060Phase 22 trials

    Suzhou Alphamab Co., Ltd. · End-Stage Renal Disease Requiring Haemodialysis, Knee Arthroplasty, Total

  • LacutoclaxPhase 22 trials

    Guangzhou Lupeng Pharmaceutical Company LTD. · Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL)

  • LAM-001Phase 22 trials

    IRulya Therapeutics Inc. · Sarcoidosis Associated Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia

  • LASN01Phase 22 trials

    Lassen Therapeutics 1 PTY LTD · Thyroid Eye Disease, Pulmonary Fibrosis, Graves Ophthalmopathy

  • LM-168Phase 22 trials

    LaNova Medicines Limited · Advanced Solid Tumor, Advanced Solid Tumours

  • LM-24C5Phase 22 trials

    LaNova Medicines Limited · Advanced Solid Tumor, Advanced Solid Tumor Cancer

  • LM-364Phase 22 trials

    LaNova Medicines Limited · Advanced Solid Tumor Cancer, Malignant Tumors

  • LM103 TILsPhase 22 trials

    Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer

  • LondamocitinibAZD4604Phase 22 trials

    AstraZeneca · Asthma

  • LorigerlimabMGD019Phase 22 trials

    MacroGenics · Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma

  • LS301-ITPhase 22 trials

    Integro Theranostics · Non Small Cell Lung Cancer (NSCLC), Breast Cancer, DCIS

  • LT3001 DrugPhase 22 trials

    Shanghai Pharmaceuticals Holding Co., Ltd · Acute Ischemic Stroke

  • LY188011Phase 22 trials

    Eli Lilly · Neoplasms, Child, Adolescent

  • LY3549492Phase 22 trials

    Eli Lilly · Obesity, Overweight

  • LY4005130Phase 22 trials

    Eli Lilly · Alopecia Areata, Vitiligo, Non-Segmental Vitiligo (NSV)

  • LY4395089Phase 22 trials

    Eli Lilly · Crohn Disease, Colitis, Ulcerative

  • M1774TuvusertibPhase 22 trials

    EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer

  • matched to VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • matching dosagePhase 22 trials

    Hangzhou Sciwind Biosciences Co., Ltd. · Weight Management, Overweight , Obesity, Overweight and/or Obesity

  • MBS314Phase 22 trials

    Beijing Mabworks Biotech Co., Ltd. · Relapsed or Refractory Multiple Myeloma, Multiple Myeloma

  • MenACWYPhase 22 trials

    LimmaTech Biologics AG · Shigellosis, Salmonella Infections

  • mivelsiranALN-APPPhase 22 trials

    Alnylam Pharmaceuticals · Cerebral Amyloid Angiopathy, Down Syndrome-Associated Alzheimer's Disease (DS-AD)

  • ML-004Phase 22 trials

    MapLight Therapeutics · Autism Spectrum Disorder

  • ModzatinibATI-2138Phase 22 trials

    Aclaris Therapeutics, Inc. · Lichen Planus, Atopic Dermatitis

NewerPage 37 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.